Jade Biosciences, Inc. share price logo

Jade Biosciences, Inc. Share Price

NASDAQ: JBIO

Small Cap

$25.34

+0.13

(+0.52%)

Live

as on

Jade Biosciences, Inc. Stock Performance

as on April 25, 2026 at 2:13 am IST

  • Day's Low

    Day's High

    $23.88
    $26.73
    downward going graph

    5.76%

    Downside

    5.49%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $6.57
    $26.33
    downward going graph

    74.09%

    Downside

    3.91%

    Upside

    downward going graph

Jade Biosciences, Inc. share price movements today

Previous Close
$25.21
Open
$25.11
Volume
436.9K
Day's Low - High
$23.88 - $26.73
52 Week Low - High
$6.57 - $26.33

Jade Biosciences, Inc. Historical Returns

1 Month Return
+ 90.12 %
3 Month Return
+ 54.62 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Jade Biosciences, Inc. Stock Fundamentals & Key Indicators

Check Jade Biosciences, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.3B

EPS (TTM)

-2.175

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-89.19%

Jade Biosciences, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Jade Biosciences, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$1.3BNANA0.00%
BUY$41.4B129.51%133.38.45%
BUY$111.3B99.68%28.5732.94%
NA$33.3BNA121.875.37%
BUY$78.9B56.77%17.9931.41%

Jade Biosciences, Inc. Stock’s Investor Sentiment and Interest

Search interest for Jade Biosciences, Inc. Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-23% versus previous 30 day period

Jade Biosciences, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2024
Dec 2024
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
Gross Profit
0
0
0
0
0
Operating Income
-14
-6
-27
-27
-34
EBITDA
-16
-5
-32
-25
-34
Interest Expense
-
-
-
-
-
Depreciation
-
-
-
0
0
Income Before Tax
-16
-5
-32
-25
-31
Income Tax Expense
-
0
-
-
0
Net Income
-16
-5
-32
-25
-67
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

Jade Biosciences, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2025
Total Revenue
-
Gross Profit
0
Operating Income
-113
EBITDA
-113
Interest Expense
-
Depreciation
0
Income Before Tax
-127
Income Tax Expense
0
Net Income
-127
Net Profit Margin
0.00%

Jade Biosciences, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-20
-23
-24
-16
-5
-38
-32
-25
-31
Operating Cash Flow
-14
-23
-20
37
-11
-
-36
-22
-33
Investing Cash Flow
5
8
18
-26
13
-
-12
-148
-98
Financing Cash Flow
0
0
24
69
0
-
190
-
170
Change in Cash
-8
-14
21
0
2
-
176
-170
-50

Jade Biosciences, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-22
-51
-75
-69
-127
Operating Cash Flow
-27
-39
-56
-71
-94
Investing Cash Flow
-113
6
11
56
-247
Financing Cash Flow
190
0
45
25
360
Change in Cash
49
-31
1
10
-33

Insights on Jade Biosciences, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, JBIO has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, JBIO stock has moved up by 826.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 53.2% return, outperforming this stock by 23.5%

About Jade Biosciences, Inc.

Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.
OrganisationJade Biosciences, Inc.
HeadquartersBuilding 23, Waltham, MA, United States, 02453
IndustryBiotechnology
CEOMr. Tom Frohlich
E-voting on sharesClick here to vote

Key Management of Jade Biosciences, Inc.

Name

Title

Dr. Jason Wright Ph.D.

Senior Vice President of Chemistry, Manufacturing & Controls

Mr. Jonathan Quick

Senior Vice President of Finance

Ms. Valerie Fauvelle

Senior Vice President of Regulatory & Quality

Ms. Amy Sullivan

Senior Vice President of Development Operations

Mr. Bradford D. Dahms Ph.D.

CFO & Treasurer

Dr. Andrew James King D.V.M., Ph.D.

Chief Scientific Officer & Head of R&D

Ms. Elizabeth Balta J.D.

Chief Legal Officer & Corporate Secretary

Ms. Lori Stewart

Senior Vice President of People

Mr. Tom Frohlich

CEO & Director

Ms. Sandy Lewis

Senior Vice President, Biometrics & Clinical Strategy

FAQs

What is Jade Biosciences, Inc. share price today?

Jade Biosciences, Inc. share price today is $25.34 as on . Jade Biosciences, Inc. share today touched a day high of $26.73 and a low of $23.88.

What is the 52 week high and 52 week low for Jade Biosciences, Inc. share?

Jade Biosciences, Inc. share touched a 52 week high of $26.33 on and a 52 week low of $6.57 on . Jade Biosciences, Inc. stock price today i.e. is trending at $25.34,which is 3.76% down from its 52 week high and 285.99% up from its 52 week low.

What is Jade Biosciences, Inc.'s market capitalisation today?

Jade Biosciences, Inc. market capitalisation is $0.00T as on .

How to invest in Jade Biosciences, Inc. Stock (JBIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Jade Biosciences, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Jade Biosciences, Inc. Shares that will get you 0.0592 shares as per Jade Biosciences, Inc. share price of $25.34 per share as on April 24, 2026 at 8:43 pm IST.

What is the minimum amount required to buy Jade Biosciences, Inc. Stock (JBIO) from India?

Indian investors can start investing in Jade Biosciences, Inc. (JBIO) shares with as little as ₹94.228 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.28 in Jade Biosciences, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Jade Biosciences, Inc. share’s latest price of $25.34 as on April 24, 2026 at 8:43 pm IST, you will get 0.3946 shares of Jade Biosciences, Inc.. Learn more about fractional shares .